The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus

CHIN-HSIAO TSENG2022-12-202022-12-202022-11-172072-6694https://scholars.lib.ntu.edu.tw/handle/123456789/626621Whether metformin might reduce the risk of multiple myeloma (MM) has not been extensively researched in humans.enTaiwan; metformin; multiple myeloma; pharmacoepidemiological study; type 2 diabetes mellitus[SDGs]SDG3The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitusjournal article10.3390/cancers14225637364287302-s2.0-85142458624WOS:000887111200001https://api.elsevier.com/content/abstract/scopus_id/85142458624